In response to the company sharing the pricing details of a recently announced secondary common stock offering, shares of Mirati Therapeutics (NASDAQ: MRTX), a red-hot clinical-stage biotech focused on cancer, jumped 10% as of 10:30 a.m. EDT on Thursday.Mirati announced on Wednesday afternoon that it intended to raise capital from a common stock offering.Here are the pricing details from the deal:Continue reading
Here's Why Mirati Therapeutics, Inc. Is Rising Today
newsfeedback@fool.com (Brian Feroldi), The Motley Fool
Thu, 06/07/2018 - 8:26am
Welcome to Wopular
Wopular is an
online newspaper rack,
giving you a summary view of the top headlines from the top news sites.
Senh Duong (Founder)
Wopular,
MWB,
RottenTomatoes
MoviesWithButter : Our Sister Site
- "Expendables 4" Starts Shooting This Fall, Says Randy Couture at the Arnold Sports Festival more
- “Expendables 4” Gets Funding Interest from “Ip Man 3” Financier more
- "Ip Man 3" Distributor Suspected of Box Office Fraud, Parent Company Loses $200M in Market Cap more
- Yen Targets "Ip Man 4" for 2018 Release; Discusses Film with Director, Producer more
- "Ip Man 3" Shatters Expectations with $72M Opening [China Box Office] more